Congenital serum prothrombin conversion accelerator (SPCA) deficiency.

H A DANN; H W FISHER; L BURNETT; D BRIGGS

doi:10.7326/0003-4819-49-2-459

Home/Archive/PubMed

PubMed · 13571832

Congenital serum prothrombin conversion accelerator (SPCA) deficiency.

H A DANN·H W FISHER·L BURNETT·D BRIGGS

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Hemorrhagic Disorders Prothrombin HEMORRHAGIC DIATHESIS/diagnosis Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

H A DANN, H W FISHER, L BURNETT, D BRIGGS. 1958. Congenital serum prothrombin conversion accelerator (SPCA) deficiency.. https://doi.org/10.7326/0003-4819-49-2-459

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Dependant factors.

Explore the source record for details and available documents.

Hemorrhagic Disorders↗

PubMed2004

Difficulty breathing. Late onset vitamin K deficiency bleeding.

Explore the source record for details and available documents.

Hemorrhagic Disorders↗

PubMed2003

Profound imbalance of pro-fibrinolytic and anti-fibrinolytic factors (tissue plasminogen activator and plasminogen activator inhibitor type 1) and severe bleeding diathesis in a patient with cirrhosis: correction by liver transplantation.

A 49-year-old male with alcoholic cirrhosis suffered several spontaneous, life-threatening, deep muscle bleeding episodes. Laboratory evaluation indicated excessive fibrinolysis with low plasminogen, low alpha2-antiplasmin, undetectable plasminogen activator inhibitor type 1 (PAI-1) activity, high tissue plasminogen activator (t-PA) activity and high t-PA antigen. Treatment with oral anti-fibrinolytic agents prevented further bleeding episodes. Decompensated cirrhosis eventually necessitated orthotopic liver transplantation. Post-operatively, the patient did not require oral anti-fibrinolytic agents, and there were no significant bleeding events. Circulating PAI-1 activity, t-PA activity and antigen normalized by 3 months post transplant. In short, the profound bleeding diathesis, as well as the imbalance in t-PA and PAI-1 levels, corrected after liver transplantation. Recognition of such patients is important, because the bleeding diathesis is an indication rather than a contraindication for orthotopic liver transplantation.

Hemorrhagic Disorders↗